Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Change in Acquisitions & Divestments (2016 - 2025)

Heron Therapeutics' Change in Acquisitions & Divestments history spans 10 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 70.87% year-over-year to $7.1 million; the TTM value through Dec 2025 reached $67.0 million, down 45.73%, while the annual FY2025 figure was $67.0 million, 45.73% down from the prior year.
  • Change in Acquisitions & Divestments reached $7.1 million in Q4 2025 per HRTX's latest filing, down from $18.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $58.0 million in Q2 2021 to a low of $7.1 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $30.3 million, with a median of $28.9 million recorded in 2023.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 86.17% in 2021, then surged 122.56% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $14.0 million in 2021, then soared by 50.0% to $21.0 million in 2022, then dropped by 29.76% to $14.8 million in 2023, then skyrocketed by 65.23% to $24.4 million in 2024, then tumbled by 70.87% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for HRTX's Change in Acquisitions & Divestments are $7.1 million (Q4 2025), $18.0 million (Q3 2025), and $16.7 million (Q2 2025).